{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:22:50Z","timestamp":1791390170826,"version":"4.3.3"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":9331,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[1981,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Four patients with non\u2010Hodgkin lymphoma and two with acute lymphocytic leukemia (ages 4 years 4 months to 16 years 6 months) exhibited a unique reaction to intravenously administered cytosine arabinoside (Ara\u2010C) given alone as a part of the previously reported LSA<jats:sub>2<\/jats:sub>\u2010L<jats:sub>2<\/jats:sub> treatment protocol. The syndrome was characterized by fever, myalgia, bone pain, and occasionally by chest pain, maculopapular rash, and conjunctivitis. Each of the eleven episodes of this syndrome occurred within 6\u201312 hours of drug infusion and always abated after cessation of Ara\u2010C. Prior to the reaction, patients had been on therapy for an average of 13.5 months during which they were exposed to 2298\u20135387 mg\/m<jats:sup>2<\/jats:sup> (mean of 3200 mg\/m<jats:sup>2<\/jats:sup>) of Ara\u2010C.<\/jats:p><jats:p>The high incidence of this syndrome (50% of our patients on the LSA<jats:sub>2<\/jats:sub>\u2010L<jats:sub>2<\/jats:sub> regimen and 33% of those receiving Ara\u2010C) has not been previously reported. Considering the prolonged exposure to Ara\u2010C and our inability to document infections in the patients or pyrogens contaminating the drug lots, the most likely explanation for this syndrome is a hypersensitivity reaction to Ara\u2010C. Prevention of these symptoms with corticosteroids supports this contention and provides a reasonable alternative to discontinuing Ara\u2010C.<\/jats:p>","DOI":"10.1002\/mpo.2950090309","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T15:01:54Z","timestamp":1171983714000},"page":"257-264","source":"Crossref","is-referenced-by-count":50,"title":["The cytosine arabinoside (Ara\u2010C) syndrome"],"prefix":"10.1002","volume":"9","author":[{"given":"R. P.","family":"Castleberry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Crist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tate","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Malluh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Gaddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"197","volume-title":"Clinical Pediatric Oncology","author":"Vietti TJ","year":"1977"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio233212a0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V32.4.507.507"},{"key":"e_1_2_1_5_2","first-page":"59","article-title":"Cytosine arabinoside (NSC 63878) therapy for acute leukemia in adults","volume":"53","author":"Bodey GP","year":"1969","journal-title":"Cancer Chem Rep"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196905)23:5<1019::AID-CNCR2820230506>3.0.CO;2-N"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4<1417::AID-CNCR2820400409>3.0.CO;2-Z"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196803)21:3<341::AID-CNCR2820210302>3.0.CO;2-F"},{"key":"e_1_2_1_9_2","first-page":"59","article-title":"Cytosine arabinoside (Ara\u2010C) and prednisone therapy of previously treated acute lymphoblastic and undifferentiated leukemia of childhood","volume":"11","author":"Nesbit M","year":"1970","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197402)33:2<539::AID-CNCR2820330232>3.0.CO;2-E"},{"key":"e_1_2_1_11_2","first-page":"287","article-title":"Cytosine arabinoside (NSC 63878) in acute leukemia in children","volume":"50","author":"Howard JP","year":"1966","journal-title":"Cancer Chem Rep"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<123::AID-CNCR2820370119>3.0.CO;2-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood.V21.3.352.352","article-title":"Megaloblastosis produced by a cytosine antagonist 1\u2010\u03b2\u2010D\u2010arabinofuranosylcytosine","volume":"21","author":"Tally RW","year":"1963","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:5<809::AID-CNCR2820200536>3.0.CO;2-0"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000224901"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)32504-4"},{"key":"e_1_2_1_17_2","first-page":"1073","article-title":"Treatment of acute myeloblastic leukemia in adults: Remission induction with a combination of cyclophosphamide, cytarabine and vincristine","volume":"107","author":"Abu\u2010Zahra H","year":"1972","journal-title":"Canad Med Assoc J"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80178-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(76)90151-2"},{"key":"e_1_2_1_20_2","first-page":"180","article-title":"Acute cyclophosphamide hypersensitivity reaction: Possible lack of cross\u2010sensitivity to mechlorethamine and isophosphamide","volume":"62","author":"Legha SS","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5832.115"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.229.12.1578b"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197709)40:3<998::AID-CNCR2820400306>3.0.CO;2-R"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197406)33:6<1491::AID-CNCR2820330604>3.0.CO;2-#"},{"key":"e_1_2_1_25_2","unstructured":"Personal communication: Dr. Kenneth Starling Baylor College of Medicine Houston Texas."},{"key":"e_1_2_1_26_2","unstructured":"Personal communication: Dr. George Royer Upjohn Co Kalamazoo Michigan."},{"key":"e_1_2_1_27_2","first-page":"427","article-title":"Bacterial pyrogens","volume":"9","author":"Bennett IL","year":"1957","journal-title":"Pharm Rev"},{"key":"e_1_2_1_28_2","first-page":"903","article-title":"Detection of endotoxin in human blood and demonstration of an inhibitor","volume":"75","author":"Levin J","year":"1970","journal-title":"J Clin Lab Med"},{"key":"e_1_2_1_29_2","first-page":"354","article-title":"Effect of ACTH and cortisone on drug hypersensitivity reactions","volume":"87","author":"Carey RA","year":"1950","journal-title":"Bull Johns Hopkins Hospital"},{"key":"e_1_2_1_30_2","first-page":"196","article-title":"Allergic reactions to therapeutic agents: Treatment with adrenocorticotropic hormone (ACTH) or cortisone","volume":"92","author":"Shulman LE","year":"1952","journal-title":"Bull Johns Hopkins Hospital"},{"key":"e_1_2_1_31_2","first-page":"149","article-title":"Drug fever","volume":"8","author":"Cluff LE","year":"1964","journal-title":"Prog Allergy"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.2950090309","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.2950090309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:29:24Z","timestamp":1699842564000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.2950090309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981,1]]}},"alternative-id":["10.1002\/mpo.2950090309"],"URL":"https:\/\/doi.org\/10.1002\/mpo.2950090309","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,1]]}}}